Overall (A), induction (B) and postinduction (C) incidence of allergic... | Download Scientific Diagram
Safety of mRNA-based COVID-19 vaccination in paediatric patients with a PEG-asparaginase allergy - EJC Paediatric Oncology
Managing asparaginase-related toxicity in adult patients - Oncology Nurse Advisor
Asparaginase Toxicities: Identification and Management in Patients With Acute Lymphoblastic Leukemia | ONS
Asparaginase: an old drug with new questions - ScienceDirect
Managing Hypersensitivity to Asparaginase in Pediatrics, Adolescents, and Young Adults | Semantic Scholar
Hypersensitivity Rates in Pediatric Patients Receiving Intravenous or Intramuscular Asparaginase Agents
Clinical Characteristics of Intravenous PEG-Asparaginase Hypersensitivity Reactions in Patients Undergoing Treatment for Acute Lymphoblastic Leukemia - Emily K. Browne, Christina Moore, April Sykes, Zhaohua Lu, Sima Jeha, Belinda N. Mandrell, 2018
Asparaginase - Wikipedia
Use of PEG-asparaginase in newly diagnosed adults with standard-risk acute lymphoblastic leukemia compared with E. coli-asparaginase: a retrospective single-center study | Scientific Reports
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
Hypersensitivity reactions to asparaginase therapy in acute lymphoblastic leukemia: immunology and clinical consequences | Future Oncology
The severity of asparaginase-induced allergies was correlated with... | Download Scientific Diagram
Consensus expert recommendations for identification and management of asparaginase hypersensitivity and silent inactivation | Haematologica
Erythrocyte encapsulated l-asparaginase (GRASPA) in acute leukemia. - Abstract - Europe PMC
How to manage asparaginase hypersensitivity in acute lymphoblastic leukemia | Future Oncology
Intravenous pegylated asparaginase versus intramuscular native Escherichia coli l-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial - ScienceDirect
Managing asparaginase-related toxicity in adult patients - Oncology Nurse Advisor
How I treat the toxicities of pegasparaginase in adults with acute lymphoblastic leukemia - ScienceDirect
Detecting and Treating Asparaginase-Related Toxicities in Acute Lymphoblastic Leukemia (Transcript)
Increase in peg-asparaginase clearance as a predictor for inactivation in patients with acute lymphoblastic leukemia | Leukemia
(PDF) Alternative algorithm for L-asparaginase allergy in children with acute lymphoblastic leukemia | Selin Aytac - Academia.edu
Implementation of the asparaginase activity assessment technique for clinical use: experience of a Brazilian Center | Scientific Reports
